Nerac

Information That Drives Innovation

We’re here to help with your research needs
+1 860 872 7000
Customer Access
  • Home
  • What We Do
    • Innovation Insights and Consulting Practice
    • Regulatory
    • Medical Device and Life Sciences
    • Technology Scouting and Innovation
    • Market Research
    • Intellectual Property
    • Commercialization Services for TTOs and Start-Ups
    • Critical Updates
  • Who We Serve
  • How to Engage
  • Why Nerac?
  • Meet our Team
    • Leadership Team
    • Our Analysts
    • Our Partners
  • Nerac Insights and Publications
    • Articles
    • Case Studies
    • Press Room
    • Videos
    • Webcasts
    • White Papers
  • Contact Us
You are here: Home / Nerac Insights / Articles / Commercialization Strategy for Innovative Products: The Importance of Considering Regulatory Implications

Commercialization Strategy for Innovative Products: The Importance of Considering Regulatory Implications

Facebook0
Google+0
LinkedIn0
Twitter0
By Donna Mitchell-Magaldi, M.S., Nerac Analyst,
Originally Published: March 8, 2016

You have a great idea for an innovative product, a granted patent, and you are ready to assess market and commercialization feasibility. Do you know the important questions you will need to answer? Possibly the most important questions are: What are the regulatory pathways you will need to navigate in order to get your innovative product approved and on the market, and what are the potential financial burdens associated with compliance?

Want to read the rest of the article? Fill out the form to download:Commercialization Strategy for Innovative Products: The Importance of Considering Regulatory Implications
Get Download Link

Related Posts

  • The Costs of Regulatory Noncompliance in the Medical Device Industry: Is it Worth the Gamble?
    73
    By Donna Mitchell-Magaldi, Nerac Analyst, The global medical device market was valued at $350 billion dollars in 2012 (Mddonline.com, 2012).  The US market was valued at $127 Billion dollars in 2013 making it the largest medical device market in the world (Prweb.com, 2013).  However, millions of dollars are lost every year due to regulatory noncompliance issues…
    Tags: device, medical, market, regulatory, read, donna, analyst, nerac, mitchell-magaldi, article
  • Understanding CFDA Expectations Regarding Clinical Literature Evaluation for Medical Devices under Order 650: A 3-Part Nerac Perspective
    69
    By Richard Conforti, M.S., Nerac Analyst, Originally Published: April-August, 2016 In 2014 the Chinese Food and Drug Administration, CFDA, updated their regulations on medical devices. These updates substantially changed the way in which a medical device company, particularly international companies not based or founded in China, registers their devices in China. In part 1 of…
    Tags: medical, article, nerac, read, order, url="http://nerac1.wpengine.com/wp-content/uploads, sdfile, rest, form, fill
  • Notified Body Audit Trends: Be in the Know!
    69
    By Donna Mitchell-Magaldi, Nerac Analyst Originally Published: February 10, 2015 It is no surprise to anyone in the medical device industry that the European Commission is working on a new regulatory framework that will in essence take the three existing directives: Directive 90/385/EEC regarding active implantable medical devices, Directive 93/42/42 regarding medical devices, and Directive…
    Tags: will, regulatory, medical, device, nerac
  • Case Studies
  • White Papers
  • Webcasts
  • Articles
    • Nerac Strategist
    • Energy
    • Food & Nutrition
    • Intellectual Property
    • Regulatory
    • Technology & Innovation
    • Medical Device & Healthcare
    • Pharmaceutical
    • Engineering
    • Market Research
    • Critical Alerts
    • Chemistry/Advanced Materials
  • Press Room

Click here to learn more about….

3d printing advanced materials aerospace Ask Kevin Videos biotech CFDA clinical literature evaluations commercialization strategies competitive intelligence Disruptive Technologies emerging markets energy EU MDR FDA food helga weires Industry 4.0 innovation Inspiring Next intellectual property intellectual property strategies IP market analysis market research medical device medical devices nerac Nerac client questions Nerac Strategist notified body audit open innovation Order 650 patenting strategies patent landscape pharmaceutical Post-Market Surveillance R&D regulatory regulatory compliance Robert Beinstein Rosemarie Szostak specialty chemicals Sustainable Development Goals technology scouting XcellR8
  • Facebook
  • Google+
  • LinkedIn
  • RSS
  • Twitter
  • YouTube
  • Career Opportunities
  • Privacy Policy

Copyright © 2022 Nerac · One Technology Drive · Tolland, CT 06084 · 1.860.872.7000

Sign Up for the Nerac Strategist

Like what you see? Sign up here to receive the Nerac Strategist newsletter, a compilation of analyst insights on rapidly developing industry issues, compliance challenges and commercial opportunities!
  • This field is for validation purposes and should be left unchanged.